TCTAP A-196 Impact of Low Dose Atorvastatin on Development of New-onset Diabetes Mellitus in Asian Population: Five-year Clinical Outcomes

The primary end-point was the cumulative incidence of new-onset DM which was defined as having a fasting blood glucose >=126 or HbA1c >=6.5%. and assessed to determine the impact of low dose atrovastatin (10mg or 20mg).

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014-04, Vol.63 (12), p.S56-S56
Main Authors: Park, Ji Young, Rha, Seung-Woon, Choi, Byoung Geol, Choi, Jae Woong, Ryu, Sung Kee, Choi, Se Yeon, Park, Yoonjee, Goud, Akkala Raghavender, Li, Hu, Lee, Sunki, Kim, Ji Bak, Im, Sung Il, Na, Jin Oh, Choi, Cheol Ung, Lim, Hong Euy, Kim, Jin Won, Kim, Eung Ju, Park, Chang Gyu, Seo, Hong Seog, Oh, Dong Joo
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Clinical outcomes
Diabetes
Internal Medicine
Medical research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The primary end-point was the cumulative incidence of new-onset DM which was defined as having a fasting blood glucose >=126 or HbA1c >=6.5%. and assessed to determine the impact of low dose atrovastatin (10mg or 20mg).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.02.239